PROGRAMMATIC FACTORS |
CLUSTER 1 Traditional Model (n = 5 clinics) |
CLUSTER 2 Mixed Model (n = 10 clinics) |
CLUSTER 3 Task-Shifted Model (n = 4 clinics) |
---|---|---|---|
Clinic days Per Week (average clinic day is 7 h) | |||
Average number of clinic days at the main ART site (min, max) | 4.6 (3,6) | 4.4 (2,6) | 4.8 (4,5) |
Average number of clinic days at outreach sites (min, max) | 3.0 (0,5) | 1.3 (0,5) | 0.5 (0,2) |
Total average number of clinic days (min, max) | 7.6 (3,11) | 5.7 (4,10) | 5.3 (5,6) |
Time to ART initiation | |||
> 7 days to determine eligibility | 0/5 (0%) | 6/10 (60%) | 2/4 (50%) |
> 7 days to initiate AT if found eligible | 1/5 (20%) | 4/10 (40%) | 2/4 (50%) |
Site requires at least 3 counselling sessions before ART initiation | 2/5 (40%) | 9/10 (90%) | 3/4 (75%) |
One or more stock out of ART in the past 6 months | 1/5 (20%) | 0/10 (0%) | 4/4 (100%) |
Time to Less Frequent ARV Drug Refill (every 2 months instead of monthly) | |||
In the first month on ART | 0/5 (0%) | 0/10 (0%) | 0/4 (0%) |
Between two and six months on ART | 0/5 (0%) | 2/10 (20%) | 0/4 (0%) |
After six months on ART | 1/5 (20%) | 8/10 (80%) | 1/4 (25%) |
Frequency of laboratory testing after 6 months on ART | |||
CD4 cell count | |||
Every 3 months | 1/5 (20%) | 2/10 (20%) | 0/4 (0%) |
Every 6 months | 4/5 (80%) | 8/10 (80%) | 4/4 (100%) |
Viral load testing | |||
Never | 2/5 (40%) | 6/10 (60%) | 3/4 (75%) |
As needed | 3/5 (60%) | 4/10 (40%) | 1/4 (25%) |
Adherence support through the HIV care and treatment clinic | |||
Require treatment supporter after ART initiation | 5/5 (100%) | 8/10 (80%) | 3/4 (75%) |
Pill count during 1st six months on ART | 0/5 (0%) | 5/10 (50%) | 3/4 (75%) |
Pill count after 1st six months on ART | 0/5 (0%) | 5/10 (50%) | 2/4 (50%) |
Pill count after patient misses ARV drug refill appointment | 4/5 (80%) | 7/10 (70%) | 3/4 (75%) |
People Living with HIV support group | 5/5 (100%) | 8/10 (80%) | 4/4 (100%) |
Adherence support worker | 4/5 (80%) | 8/10 (80%) | 3/4 (75%) |
Home-based care worker | 3/5 (60%) | 5/10 (50%) | 2/4 (50%) |
Community-based services linked to the HIV care and treatment clinic | |||
ARV drug distribution by providers or lay volunteers | 0/5 (0%) | 3/10 (30%) | 1/4 (25%) |
Adherence support | 5/5 (100%) | 8/10 (80%) | 4/4 (100%) |
Emotional or social support | 4/5 (80%) | 8/10 (80%) | 3/4 (75%) |
Follow-up of missed appointments | 4/5 (80%) | 7/10 (70%) | 3/4 (75%) |
Nutritional supplementation | 3/5 (60%) | 5/10 (50%) | 3/4 (75%) |
Home based care | 4/5 (80%) | 7/10 (70%) | 4/4 (100%) |
Referral for medical care | 4/5 (80%) | 7/10 (70%) | 4/4 (100%) |
Follow-up of missed clinic or pharmacy appointment | |||
Telephone contact | 4/5 (80%) | 9/10 (90%) | 4/4 (100%) |
House visit by adherence support worker | 3/5 (60%) | 8/10 (80%) | 3/4 (75%) |
House visit by healthcare worker | 1/5 (20%) | 5/10 (50%) | 1/4 (25%) |
House visit by home-based care worker | 3/5 (60%) | 7/10 (70%) | 3/4 (75%) |
Tracing of patients loss to follow-up | |||
Telephone contact | 4/5 (80%) | 9/10 (90%) | 4/4 (100%) |
House visit by adherence support worker | 4/5 (80%) | 8/10 (80%) | 2/4 (50%) |
House visit by healthcare worker | 3/5 (60%) | 5/10 (50%) | 1/4 (25%) |
House visit by home-based care worker | 3/5 (60%) | 7/10 (70%) | 1/4 (25%) |